GBA‐Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort

Variants in GBA are the most common genetic risk factor for Parkinson's disease (PD). The impact of different variants on the PD clinical spectrum is still unclear.

[1]  M. Nalls,et al.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. , 2009, The New England journal of medicine.

[2]  M. Ban,et al.  Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort. , 2013, Brain : a journal of neurology.

[3]  K. Marder,et al.  Differential effects of severe vs mild GBA mutations on Parkinson disease , 2015, Neurology.

[4]  M. T. Pellecchia,et al.  Impulsive-compulsive behaviors in parkin-associated Parkinson disease , 2016, Neurology.

[5]  An exome study of Parkinson’s disease in Sardinia, a Mediterranean genetic isolate , 2014, neurogenetics.

[6]  E. Beutler,et al.  Glucocerebrosidase Mutations in Gaucher Disease , 1994, Molecular medicine.

[7]  R. Núñez,et al.  Residual enzymatic activity as a prognostic factor in patients with Gaucher disease type 1: correlation with Zimran and GAUSS-I index and the severity of bone disease. , 2016, QJM : monthly journal of the Association of Physicians.

[8]  A. Quattrone,et al.  Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy , 2008, Movement disorders : official journal of the Movement Disorder Society.

[9]  A. Singleton,et al.  Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal , 2009, Neurobiology of Aging.

[10]  K. Marder,et al.  Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease , 2007, Neurology.

[11]  D. Berg,et al.  GBA‐associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study , 2015, Movement disorders : official journal of the Movement Disorder Society.

[12]  A. Singleton,et al.  Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. , 2009, Brain : a journal of neurology.

[13]  D. Berg,et al.  Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha‐Synuclein Profiles , 2020, Movement disorders : official journal of the Movement Disorder Society.

[14]  M. Horowitz,et al.  The enigma of the E326K mutation in acid β-glucocerebrosidase. , 2011, Molecular genetics and metabolism.

[15]  M. Albert,et al.  Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. , 2016, JAMA neurology.

[16]  A. Singleton,et al.  Disease modification and biomarker development in Parkinson disease , 2020, Neurology.

[17]  W. Chung,et al.  Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. , 2015, Brain : a journal of neurology.

[18]  A. Mirelman,et al.  Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene. , 2018, Parkinsonism & related disorders.

[19]  S. Tiamkao,et al.  Glucocerebrosidase mutations in Thai patients with Parkinson's disease. , 2014, Parkinsonism & related disorders.

[20]  I. Guella,et al.  Glucocerebrosidase mutations in primary parkinsonism , 2014, Parkinsonism & related disorders.

[21]  Nir Giladi,et al.  Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset , 2008, Neurology.

[22]  A. Schapira,et al.  Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort. , 2015, JAMA neurology.

[23]  Nir Giladi,et al.  Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations. , 2009, Brain : a journal of neurology.

[24]  J. Hardy,et al.  The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[25]  M. Edwards,et al.  Can we predict development of impulsive–compulsive behaviours in Parkinson’s disease? , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[26]  B. Tang,et al.  A Meta-Analysis of GBA-Related Clinical Symptoms in Parkinson's Disease , 2018, Parkinson's disease.

[27]  F. H. van der Westhuizen,et al.  A molecular analysis of the GBA gene in Caucasian South Africans with Parkinson's disease , 2017, Molecular genetics & genomic medicine.

[28]  E. Dardiotis,et al.  β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease. , 2011, Molecular genetics and metabolism.

[29]  C. Mariani,et al.  Survival and dementia in GBA‐associated Parkinson's disease: The mutation matters , 2016, Annals of neurology.

[30]  J. Hardy,et al.  Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course , 2012, Movement disorders : official journal of the Movement Disorder Society.

[31]  R. Barker,et al.  Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's , 2016, Annals of neurology.

[32]  M. Vidailhet,et al.  Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease. , 2011, Human molecular genetics.

[33]  G. Rouleau,et al.  GBA p.T369M substitution in Parkinson disease: Polymorphism or association? A meta-analysis , 2016, Neurology: Genetics.